Overview
This session will highlight key topics from the conference, including lung cancer epidemiology in Africa, barriers to diagnosis and treatment, and the evolving landscape of clinical trials in Sub-Saharan Africa.
- Describe the importance of building clinical trial infrastructure in low- and middle-income countries, including key barriers, solutions, and strategies for collaboration to improve access to novel lung cancer treatments in Africa.
- Develop actionable strategies for initiating and sustaining lung cancer patient advocacy efforts by identifying regional challenges and co-creating solutions in collaboration with patients, caregivers, and experienced advocates.
- Apply current evidence on the role of systemic therapy in early-stage non-small cell lung cancer (NSCLC) to inform treatment planning and improve patient outcomes in resource-constrained settings.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Describe the importance of building clinical trial infrastructure in low- and middle-income countries, including key barriers, solutions, and strategies for collaboration to improve access to novel lung cancer treatments in Africa.
- Develop actionable strategies for initiating and sustaining lung cancer patient advocacy efforts by identifying regional challenges and co-creating solutions in collaboration with patients, caregivers, and experienced advocates.
- Apply current evidence on the role of systemic therapy in early-stage non-small cell lung cancer (NSCLC) to inform treatment planning and improve patient outcomes in resource-constrained settings.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Share
Participants
Alex A. Adjei
MD, PhD, FACP
Chairman
Taussig Cancer Institute, Cleveland Clinic, Ohio, United States
Ronwyn van Eeden
MD
Medical Oncologist
Chris Hani Baragwanath Academic Hospital
Caleb Egwuenu
Patient Advocate
Stand Up to Cancer Nigeria
Mansoor Saleh
MD
Chair of Hematology
Aga Khan University